Today’s top gainers include the company Celgene Corporation (NASDAQ:CELG) which is in the industry Biotechnology, gaining 1.71% today. In the last week its performance is -4.48%, and 3.80% for the past quarter. Currently, Celgene Corporation, CELG has a target price of 137.43, so today’s gain of 1.71% is a significant step towards its target price. The GAP today is therefore 0.63%.
Celgene Corporation (NASDAQ:CELG), has a market cap of 81073.47, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 79.30%.
At the current price of 104.53, it has a dividend yield of *TBA, and its target price is 137.43. This is with a profit margin of 18.90%, and total debt/equity of 0. Celgene Corporation (NASDAQ:CELG) has a P/E of 43.88, as well as a forward P/E of 14.95.
With a current EPS of 2.38, and a forecasted EPS growth for next year at 22.51%,Celgene Corporation (NASDAQ:CELG) has had a EPS growth for the past five years at 15.70%. For the next five years EPS growth is projected to be 21.87%.
Performance for the year is -7.38%. Since its IPO date on 3/26/1990, the total performance to date is -12.72%.
Volume today for Celgene Corporation (NASDAQ:CELG), is 4644300, while its average volume is 4161.49. Whilst the total gain today was 1.71%, it did have a day high of -11.34%.
Volatility for this week has been at 2.69%, and 2.11% for the month. The 52-week low for Celgene Corporation, CELG has been 12.34%, while the 52-week-high has reached -18.58%.
Looking at its return of investments, which is 8.90%, and its return on assets is 7.20%. Celgene Corporation (NASDAQ:CELG) has an operating margin of 27.10%. With a sales growth of 20.90% quarter over quarter. Bearing in mind that Celgene Corporation, CELG is in the sector Healthcare, its long-term debt/equity is 2.58, and has a current ratio of 4.6 and 4.4 for quick ratio.
So what is the value of Celgene Corporation? Well its PEG is 2.01, and the P/S is 7.98, along with a P/B of 14.62. Meanwhile it has a p/cash of 12.66.